- Pulmonary reactions
- Acute reactions are hypersensitivity; chronic interstitial pneumonitis and fibrosis are linked to continuous use for months. Management: Stop at the first sign; weigh benefit against risk and watch lung status during long-term use, especially in older adults.
- Peripheral neuropathy
- The drug accumulates when renal excretion is impaired; anemia, diabetes, electrolyte imbalance, and vitamin B deficiency add risk. Management: Avoid when creatinine clearance is under 60 mL/min and stop at the first paresthesias.
- Hemolytic anemia
- Oxidant stress on red cells lacking G6PD, or with immature enzyme systems in newborns. Management: Avoid at term and in neonates; stop if hemolysis occurs.
- Treatment failure outside the bladder
- Plasma and tissue levels stay low because the drug concentrates in urine. Management: Use an agent with tissue penetration for pyelonephritis or systemic infection.